AVANIR Pharmaceuticals Completes Public Offering of 20M Shares
AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that it has completed the previously announced underwritten public offering of 20,000,000 shares of its common stock, offered at a price of $4.40 per share.
The net proceeds to AVANIR from the sales of shares in this offering, after deducting customary underwriting discounts and commissions, were approximately $83.2 million.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.